DISCO Pharmaceuticals Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $41.8M

  • Investors
  • 7

DISCO Pharmaceuticals General Information

Description

Operator of a surfaceome mapping platform intended to improve patient care using transformative cell discovery technology. The company's technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner and permits unraveling comprehensive target information that neither standard proteomics nor genome or transcriptome sequencing can provide, enabling companies with cancer-selective therapies, with the potential to boost efficacy and reduce side effects for patients.

Contact Information

Website
discopharma.de
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Gottfried-Hagen-Straße 60-62
  • 51105 Cologne
  • Germany
+49 0221
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Gottfried-Hagen-Straße 60-62
  • 51105 Cologne
  • Germany
+49 0221

DISCO Pharmaceuticals Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DISCO Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 11-Dec-2025 $41.8M Completed Generating Revenue
2. Seed Round 16-Jan-2024 Completed Generating Revenue
1. University Spin-Out 01-Jul-2022 Completed Startup
To view DISCO Pharmaceuticals’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

DISCO Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a surfaceome mapping platform intended to improve patient care using transformative cell discovery technolog
Drug Discovery
Cologne, Germany
37 As of 2025

Madison, WI
 

San Antonio, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

DISCO Pharmaceuticals Competitors (2)

One of DISCO Pharmaceuticals’s 2 competitors is Centrose, a Venture Capital-Backed company based in Madison, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Centrose Venture Capital-Backed Madison, WI
Emtora Biosciences Venture Capital-Backed San Antonio, TX
You’re viewing 2 of 2 competitors. Get the full list »

DISCO Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DISCO Pharmaceuticals Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ackermans & van Haaren Growth/Expansion Minority
NRW BANK Investment Bank Minority
AbbVie Ventures Corporate Venture Capital Minority
M Ventures Corporate Venture Capital Minority
Panakes Partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

DISCO Pharmaceuticals FAQs

  • When was DISCO Pharmaceuticals founded?

    DISCO Pharmaceuticals was founded in 2022.

  • Where is DISCO Pharmaceuticals headquartered?

    DISCO Pharmaceuticals is headquartered in Cologne, Germany.

  • What is the size of DISCO Pharmaceuticals?

    DISCO Pharmaceuticals has 37 total employees.

  • What industry is DISCO Pharmaceuticals in?

    DISCO Pharmaceuticals’s primary industry is Drug Discovery.

  • Is DISCO Pharmaceuticals a private or public company?

    DISCO Pharmaceuticals is a Private company.

  • What is DISCO Pharmaceuticals’s current revenue?

    The current revenue for DISCO Pharmaceuticals is .

  • How much funding has DISCO Pharmaceuticals raised over time?

    DISCO Pharmaceuticals has raised $63.7M.

  • Who are DISCO Pharmaceuticals’s investors?

    Ackermans & van Haaren, NRW BANK, AbbVie Ventures, M Ventures, and Panakes Partners are 5 of 7 investors who have invested in DISCO Pharmaceuticals.

  • Who are DISCO Pharmaceuticals’s competitors?

    Centrose and Emtora Biosciences are competitors of DISCO Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process